Rexnord (RXN) Reports In-Line Q4 EPS, Q1 & FY16 Guidance Comes in Light
Get Alerts RXN Hot Sheet
Join SI Premium – FREE
Rexnord (NYSE: RXN) reported Q4 EPS of $0.54, in-line with the analyst estimate of $0.54. Revenue for the quarter came in at $519 million versus the consensus estimate of $547.87 million.
Rexnord sees FY2016 EPS of $1.53-$1.63, versus the consensus of $1.52.
Rexnord sees Q1 2016 EPS of $0.26-$0.28, versus the consensus of $0.30. Rexnord sees Q1 2016 revenue of $467-477 million, versus the consensus of $501.87 million.
For earnings history and earnings-related data on Rexnord (RXN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Humana soars, Alignment Healthcare sinks on Medicare rating changes
- Constellation Brands (STZ) Beats Q2 EPS by 13c, Revenue Beats, Offers Guidance
- Neogen Corp. (NEOG) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share